Clinical trial · Observational
Blood Collection From Individuals With Lung Disease for Genetic Studies
Collection of Blood for Gene Expression/Genomic Studies in Individuals With Chronic Lung Disease
NCT00362739CI-TRIAL-00021972completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a research study where researchers are collecting blood to evaluate the genetic characteristics of individuals with chronic lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, cystic fibrosis, and lung cancer.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Asthma | — | UNRESOLVED | — |
| COPD | — | UNRESOLVED | — |
| Cystic Fibrosis | — | UNRESOLVED | — |
| Interstitial Lung Disease | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- 1: Lung Disease
- description
- Individuals with at least one of the following: (1)symptoms consistent with pulmonary disease; (2) chest X-ray consistent with lung disease; (3) pulmonary function tests consistent with lung disease; (4) lung biopsy consistent with lung disease; (5) family history of lung disease; (6) patients with diseases of organs with known association with lung disease; (7) individuals suspected of history of lung diseased based on history and/or physical examination
- label
- 2: Normal Controls
- description
- Individuals without a history of lung disease
Primary outcomes (1)
- measure
- Establish a set of normal ranges for various parameters in healthy individual specimens and compare to specimens from individuals with lung disease to determine parameters resulting in disease susceptibility and severity.
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Must provide informed consent * Males and females, age 18 years and older * Lung disease proven by at least one of the following: * symptoms consistent with pulmonary disease * chest X-rays consistent with lung disease * pulmonary function tests consistent with lung disease * lung biopsy consistent with lung disease * family history of lung disease * disease of organs with know associated with lung disease * individuals suspected of history of lung disease based on history and/or physical examination * normal controls (individuals without history of lung disease) to be sampled to provide a comparison to the lung disease cohort. Exclusion Criteria: * Drug and/or alcohol abuse within the past six months * Females who are pregnant or nursing
References
Publications (0)
Data not yet available
No reference posted for this study.